Skip to content
Peptigraph home

Peptides for Anxiety

The peptides people most often research for anxiety, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
Peptides listed
3
With human trials
2
FDA approved (any use)
1
Showing 3 peptides · ordered by search interest for this goal
  1. SelankTuftsin analogHuman RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2015, PMID 26356395Human7Animal27Summarised10Not FDA approved · research chemicalFor anxietyOverview
  2. SemaxACTH(4-10) analogAnimal evidence, 2 of 4Neuroscience and behavioral physiology 2004, PMID 15341218Human2Animal18Summarised1PCAC voted 8–5 for 503A (Jul 2026)Overview
  3. TirzepatideGLP-1 / GIP dual agonistHuman RCT evidence, 4 of 4Obesity 2026, PMID 41537305Human13Animal1Summarised1FDA approved (Mounjaro, Zepbound)For anxietyOverview
Read this first

What this list does not show

Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.

Search interest is not evidence

This list follows what people search for and discuss. It says nothing about how well any peptide works.

Animal results may not carry over

Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.

Approval covers specific uses

An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.

Combinations are a separate question

Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.

What anxiety is, and when it is a disorder

MedlinePlus separates ordinary anxiety, which it says can be a normal reaction to stress, from anxiety disorders where the fear is not temporary and can be overwhelming.[4]

The same page names generalised anxiety disorder, panic disorder and phobias as the main types, and the Selank trials below were run mostly in generalised anxiety.[4]

Selank has small human trials; Semax does not

Selank shows 7 human-only and 27 animal papers with 2 randomised trials, while Semax has 2 human-only papers and 18 animal papers for anxiety.

Calculated from source our PubMed count ledger ledger (PubMed title/abstract counts, 2026-10-02); selank human only 7, animal only 27, rct 2; semax human only 2, animal only 18, rct 0. Formula: Counts copied from each peptide ledger: humanOnly = human studies not also tagged animal, animalOnly = animal studies not tagged human, rct = human randomised trials. They count papers mentioning the topic, not positive results.

The most specific human result is a randomised comparison with medazepam in generalised anxiety, where the anxiety-reducing effect of the two drugs was similar.[5]

A controlled trial in phobic-anxiety disorders described pronounced anxiolytic effects, and these trials were small.[6]

When Selank was added to the benzodiazepine phenazepam, side-effects of the tranquilliser fell.[1]

Animal work is mixed: in mice, Selank reduced anxiety-like behaviour in one strain but had no effect in the other.[7]

Rat studies of Semax are about behavioural damage after a toxin, not anxiety disorders directly.[2]

Mood findings for the GLP-1 drug on this list conflict

A post hoc analysis of the SURMOUNT tirzepatide trials in adults with obesity found fewer participants moved to a worse depression category than on placebo.[3]

A large observational study reached the opposite conclusion for GLP-1 drugs, reporting higher risks of depression, anxiety and suicidal behaviour, a signal that observational designs cannot settle.[8]

A separate observational study of semaglutide found no higher risk of neuropsychiatric adverse outcomes versus other diabetes drugs.[9]

Common questions

What are the best peptides for anxiety?

Selank has the most human evidence, including a randomised comparison where its anxiety-reducing effect matched medazepam.[5]

Are there peptides for stress?

The listed peptides have anxiety data rather than stress data; the closest finding is a Selank trial in phobic-anxiety patients.[6]

What is the best peptide for anxiety?

No head-to-head trial exists, so Selank is only the best-studied, and its trials are small.[6]

Does Selank have side effects?

A plasma enzyme study states that Selank does not cause the side effects typical of most anxiety drugs, a statement from a plasma enzyme study, not a safety trial.[10]

Sources

  1. 1[Optimization of the treatment of anxiety disorders with selank].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2015PMID 26356395Accessed 2 Oct 2026
  2. 2The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system.Neuroscience and behavioral physiology · 2004PMID 15341218Accessed 2 Oct 2026
  3. 3Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.Obesity (Silver Spring, Md.) · 2026PMID 41537305Accessed 2 Oct 2026
  4. 4Official web pageOfficial web page · web page
  5. 5[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008PMID 18454096Accessed 2 Oct 2026
  6. 6[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014PMID 25176261Accessed 2 Oct 2026
  7. 7Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions.Bulletin of experimental biology and medicine · 2002PMID 12432865Accessed 2 Oct 2026
  8. 8The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.Scientific reports · 2024PMID 39424950Accessed 2 Oct 2026
  9. 912-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study.EClinicalMedicine · 2024PMID 39764175Accessed 2 Oct 2026
  10. 10The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.Bulletin of experimental biology and medicine · 2001PMID 11550013Accessed 2 Oct 2026

Found an error? Report a correction.